Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Understand the scenarios where a cash back credit card is the best choice. Make your spending count with this guide.
26,647 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
The YieldMax TSLA Option Income Strategy ETF drew attention in 2024 for big payouts and a high-yield claim, but its s...
A fictional case study shows how fame, branding, and sudden leadership shifts test personal finances. Learn actionabl...
Ark Invest disclosed a new Alphabet stake, triggering debate over Google’s growth drivers and the broader tech rally....
A three-way push for space-based AI puts Elon Musk and Jeff Bezos in a high-stakes orbit with a rising rival coalitio...
In 2022, the S&P 500 tumbled as inflation hung over markets, but healthcare ETFs held up better. This piece examines ...
SpaceX signals a mega IPO that could raise up to $75 billion, potentially becoming the largest stock market debut in ...
Poet Technologies stock faces a pivotal year as the company aims to move from pilots to mass production in a booming ...
President Trump urges a DOJ review into potential oil pricing abuses as wholesale costs fall but pump prices lag. The...
Tokenized stocks emerge altcoin as a lifeline for investors seeking real-world asset exposure, even as traditional al...
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Stock splits often signal strong momentum. Here are three stock-split stocks before they soar, with practical analysi...